USP CHAPTER 51 Chapter 51, Antimicrobial Effectiveness Testing of the United States Pharmacopeia, has been in existence for quite some time. In fact it was known previously as …
USP Chapter 51-AET is used to determine the preservative adequacy of an unused product formulation. In-use testing is performed to determine what happens to the microbial content of …
TRAINING - Microbiology Forum
The Microbiology Network provides expert consultation, microbiology quality assurance training, and expert witness services to pharmaceutical, medical device, and over-the-counter …
THINKING ABOUT USP CHAPTER <61> MICROBIOLOGICAL EXAMINATION OF NONSTERILE PRODUCTS: MICROBIAL ENUMERATION TESTS by David A. Porter, Ph.D.
Chapter <51> Background
Chapter <51> Background Material USP chapter <51> Antimicrobial Effectiveness Testing is designed to determine whether a product containing an antimicrobial agent is adequately …
General - Pharmaceutical Microbiology Forum
USP <51> Criteria for Fungal Organisms Started by Microbugge in General: Hello all, I'm wondering if the group has an opinion about why the USP <51> test criteria for fungal …
I would refer you to USP <1115> Bioburden control in Non-sterile Pharmaceutical Product for a discussion of the hierarchy of microbial contamination risk. The pharmaceutical ingredients, …
CU October 9 2023Date of This Update: October 9, 2023
Questionable Decisions with the USP <72> Revision
In terms of <72> I disagree with the title change from sterility to contamination testing (sterility testing but not contamination is a specification in USP monographs), reducing the suitability …
INTRODUCTION Welcome to the PMF training module covering the SOP “Performance Verification of Autoclaves”. The version in this training module has been updated and is …